hydralazine has been researched along with nitrates in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (66.18) | 18.7374 |
| 1990's | 5 (7.35) | 18.2507 |
| 2000's | 7 (10.29) | 29.6817 |
| 2010's | 8 (11.76) | 24.3611 |
| 2020's | 3 (4.41) | 2.80 |
| Authors | Studies |
|---|---|
| Schrey, A | 1 |
| Mathey, D | 1 |
| Brundage, BH; Chatterjee, K; Ports, TA | 1 |
| Halawa, B | 1 |
| Lloyd, EA | 1 |
| Awan, NA; Mason, DT; Miller, RR | 1 |
| Meller, J; Packer, M | 1 |
| Cohn, JN; Franciosa, JA | 2 |
| Amsterdam, EA; Awan, N; Mason, DT; Miller, RR | 1 |
| Armstrong, PW | 1 |
| Franciosa, JA | 1 |
| Chaudhuri, G; Cuevas, JM; Ignarro, LJ; Vargas, HM | 1 |
| Assmann, I | 1 |
| Hughes, JD; Rubin, LJ | 1 |
| Berges, W; Frieling, T; Wienbeck, M | 1 |
| Elkayam, U; Frishman, WH; Rubin, JN; Widerhorn, J | 1 |
| Ruggie, N | 1 |
| Guyatt, GH | 1 |
| Sutton, FJ | 1 |
| Conradson, TB; Rydén, L | 1 |
| Crozier, RE; Dai, RC; Ellis, FH; Gibb, SP; Micheli, KR | 1 |
| Abrams, J | 1 |
| Gautieri, RF; Ward, CO | 1 |
| Le Lorie, J; López, J; Pardo, EG; Vargas, R | 1 |
| Opie, LH | 1 |
| Bodem, G; Ochs, HR | 1 |
| Alexander, RW; Braunwald, E; Colucci, WS; Williams, GH | 1 |
| Chatterjee, K; Schwartz, AB | 1 |
| Larbig, D; Nasse, H | 1 |
| Richardson, PJ; Timmis, AD | 1 |
| Chatterjee, K; Parmley, WW | 1 |
| Chatterjee, K; Haughom, F; Massie, B; O'Young, J; Ostland, J; Parmley, W; Ports, T | 1 |
| Khomenko, VL; Pomerantsev, VP; Vasiuk, IuA | 1 |
| Franciosa, JA; Pierpont, G | 1 |
| Deglin, SM; Mandell, HN | 1 |
| Rutishauser, W | 1 |
| Chatterjee, K; Massie, BM; Rouleau, JL | 1 |
| Gasanova, AS; Serbin, VI | 1 |
| Hernandez, J; Owens, CW | 1 |
| Segal, BL | 1 |
| Cabaniss, CD | 1 |
| Giles, TD | 1 |
| Corbalán, R; Jalil, J; Kunstmann, S | 1 |
| Cohn, JN | 1 |
| Abe, Y; Chen, QH; Kosaka, H; Tian, RX; Yamamoto, A; Yoneyama, H; Zhang, L; Zhou, MS | 1 |
| de Denus, S; Spinler, SA | 1 |
| SCHRIEVER, K | 1 |
| Bolenbaugh, J; Green, PR; Levine, AB; Levine, TB | 1 |
| Chen, JJ; Cheng, PY; Yen, MH | 1 |
| Nissen, SE | 1 |
| Münzel, T | 1 |
| Beresewicz, A; Klemenska, E | 1 |
| Albajrami, O; Bellumkonda, L; Jacoby, D | 1 |
| Butler, J; Fonarow, GC; Georgiopoulou, VV; Gheorghiade, M; Gupta, D; Kalogeropoulos, AP; Konstam, MA; Marti, CN; Yancy, CW | 1 |
| Clark, AL; Cleland, JG; Farag, M; Mabote, T; Nabhan, AF; Shoaib, A; Zhang, J | 1 |
| Daiber, A; Gori, T; Keaney, JF; Maack, C; Münzel, T | 1 |
| Bowlin, B; Finch, C; Hartmann, J; Reedus, J; Richardson, A; Sands, CW; Self, T; Tolley, E | 1 |
| Cowger, JA; Guglin, ME; Johnson, FL; Kittleson, MM; Mountis, MM; Patel, CB; Patel, PC; Rame, JE; Stevenson, LW; Stewart, GC; Teuteberg, JJ | 1 |
| Butler, J; Hamo, CE; Papadimitriou, L | 1 |
| Al-Mohammad, A | 1 |
| Guglin, M; Ilonze, OJ | 1 |
| Heidenreich, PA; Kohsaka, S; Lewis, EF; Sandhu, AT; Turakhia, MP | 1 |
| Ghaznavi, Z; Jackevicius, CA; Lu, L; Warner, AL | 1 |
27 review(s) available for hydralazine and nitrates
| Article | Year |
|---|---|
[Use of vasodilator agents in circulatory insufficienty].
Topics: Blood Circulation; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1979 |
The use of vasodilator agents in the treatment of heart failure.
Topics: Cardiac Output; Cardiomegaly; Catheterization; Chronic Disease; Coronary Vessels; Dose-Response Relationship, Drug; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroprusside; Oxygen Consumption; Prazosin; Stroke Volume; Vasodilation; Vasodilator Agents | 1979 |
Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
Topics: Acute Disease; Dopamine; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroprusside; Prazosin; Vasodilator Agents | 1978 |
Oral vasodilator therapy for chronic heart failure: a plea for caution.
Topics: Cardiac Output; Chronic Disease; Forecasting; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vascular Resistance; Vasodilator Agents | 1978 |
Vasodilator therapy of cardiac failure: (first of two parts).
Topics: Blood Vessels; Diuretics; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Trimethaphan; Vasodilator Agents | 1977 |
[The extension of heart failure therapy with vasodilators].
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vasodilator Agents | 1990 |
Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aminorex; Anticoagulants; Autoimmune Diseases; Calcium Channel Blockers; Captopril; Child; Contraceptives, Oral; Cyclooxygenase Inhibitors; Diazoxide; Epoprostenol; Female; Heart Transplantation; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Infant; Liver Diseases; Lung Transplantation; Male; Middle Aged; Nitrates; Thromboembolism | 1986 |
Therapeutic advances in oesophageal motility disorders.
Topics: Adrenergic Agonists; Benzamides; Calcium Channel Blockers; Dilatation; Esophageal Achalasia; Esophageal Diseases; Esophagus; Humans; Hydralazine; Nitrates; Parasympatholytics; Parasympathomimetics; Peristalsis; Spasm; Sympatholytics | 1987 |
Cardiovascular drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Agents; Digoxin; Female; Humans; Hydralazine; Nitrates; Nitroprusside; Pregnancy; Pregnancy Complications, Cardiovascular | 1987 |
Congestive heart failure.
Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents | 1986 |
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Diuretics; Heart Diseases; Humans; Hydralazine; Nitrates; Piperazines; Prazosin; Pyridines; Research Design | 1986 |
Vasodilators for chronic congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vasodilator Agents | 1988 |
Vasodilator therapy.
Topics: Administration, Oral; Captopril; Cardiac Output; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Physical Exertion; Prazosin; Random Allocation; Stroke Volume; Time Factors; Vasodilator Agents | 1986 |
Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Drug Tolerance; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oligopeptides; Parasympatholytics; Phenoxybenzamine; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1981 |
Vasodilator therapy in chronic congestive heart failure.
Topics: Captopril; Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Minoxidil; Nitrates; Piperazines; Vasodilator Agents | 1983 |
Vasodilator therapy for chronic heart failure.
Topics: Captopril; Chronic Disease; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Physical Exertion; Prazosin; Vasodilator Agents | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Cardiovascular clinical pharmacology of impedance reducing agents.
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1981 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitrates; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Rheumatic Heart Disease; Stroke Volume; Vasodilator Agents | 1982 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
[Vasodilator agents in chronic heart failure: which is the best option?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Multicenter Studies as Topic; Nitrates; Survival Analysis; Vasodilator Agents; Ventricular Function, Left | 1993 |
Is there a role for endothelin in the natural history of heart failure?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Receptors, Endothelin; Vasodilator Agents | 1996 |
[Recent findings on nitrates: their action, bioactivation and development of tolerance].
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Coronary Disease; Drug Tolerance; Endothelium, Vascular; Guanylate Cyclase; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Molsidomine; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Oxidative Stress; Pentaerythritol Tetranitrate; Reactive Oxygen Species; Vasodilation; Vasodilator Agents | 2008 |
Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
Topics: Aldehyde Dehydrogenase; Biotransformation; Drug Therapy, Combination; Drug Tolerance; Endothelium, Vascular; Ethanol; Humans; Hydralazine; Mitochondria; Nitrates; Oxidative Stress; Reactive Oxygen Species; Sympathetic Nervous System; Tachyphylaxis; Vasodilation; Vasodilator Agents | 2009 |
Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Mortality; Nitrates; Vasodilator Agents | 2015 |
Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cardiovascular System; Drug Therapy, Combination; Exercise Therapy; Heart Failure, Diastolic; Heart Failure, Systolic; Humans; Hydralazine; Mitochondria; NADPH Oxidases; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Phosphodiesterase Inhibitors; Reactive Oxygen Species; Stroke Volume; Vitamins; Xanthine Oxidase | 2015 |
Heart Failure Guidelines on Pharmacotherapy.
Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Diuretics; Drug Combinations; Heart Failure; Humans; Hydralazine; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Nitrates; Practice Guidelines as Topic; Severity of Illness Index; Stroke Volume; Tetrazoles; Valsartan; Vasodilator Agents | 2017 |
4 trial(s) available for hydralazine and nitrates
| Article | Year |
|---|---|
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Diuretics; Heart Diseases; Humans; Hydralazine; Nitrates; Piperazines; Prazosin; Pyridines; Research Design | 1986 |
Aspects on "traditional" vasodilators in the treatment of chronic heart failure.
Topics: Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Physical Exertion; Random Allocation; Time Factors; Vasodilator Agents | 1986 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus; Disease Progression; Female; Heart Failure; Humans; Hydralazine; Hyperlipidemias; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nitrates; Patient Discharge; Patient Readmission; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume | 2016 |
39 other study(ies) available for hydralazine and nitrates
| Article | Year |
|---|---|
Treatments for heart-failure: stimulation or unloading ?
Topics: Heart Failure; Humans; Hydralazine; Myocardial Contraction; Nitrates; Phentolamine; Stimulation, Chemical; Vasodilator Agents | 1979 |
[New nitrate indications].
Topics: Dihydralazine; Drug Combinations; Heart Diseases; Humans; Hydralazine; Isosorbide Dinitrate; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Vasodilator Agents | 1978 |
[Vasodilator therapy of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1979 |
Nonparenteral vasodilator therapy for chronic congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Prazosin; Vasodilator Agents | 1979 |
Afterload reduction in congestive heart failure.
Topics: Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1978 |
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1979 |
Outflow resistance as a regulator of left ventricular performance.
Topics: Blood Pressure; Cardiac Output; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Myocardial Contraction; Nitrates; Nitroprusside; Vascular Resistance; Vasodilator Agents | 1978 |
Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Delayed-Action Preparations; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Hypertension; Nitrates; Nitroprusside; Physical Exertion; Posture; Pressure; Time Factors; Vasodilator Agents | 1978 |
Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Hydralazine; In Vitro Techniques; Male; Nitrates; Nitric Acid; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Penicillamine; Phenylephrine; Rats; Rats, Inbred Strains; S-Nitroso-N-Acetylpenicillamine; Sympathetic Nervous System; Vasodilation; Vasopressins | 1991 |
Esophageal spasm. A possible cause of atypical chest pain.
Topics: Antacids; Chest Pain; Esophageal Diseases; Humans; Hydralazine; Hydrochloric Acid; Manometry; Nitrates; Spasm | 1986 |
Vasodilator therapy for chronic congestive heart failure.
Topics: Captopril; Cardiac Catheterization; Heart Failure; Hospitalization; Humans; Hydralazine; Myocardial Contraction; Nitrates; Nitroglycerin; Prazosin; Pressure; Vascular Resistance; Vasodilator Agents; Veins | 1985 |
Effect of certain drugs on perfused human placenta. 8. Angiotensin-II antagonists.
Topics: Acetates; Angiotensin II; Atropine; Blood Pressure Determination; Cobalt; Cocaine; Cyproheptadine; Dibenzylchlorethamine; Dipyridamole; Ethanol; Female; Furans; Glycols; Humans; Hydralazine; In Vitro Techniques; Isosorbide Dinitrate; Muscles; Nitrates; Nitrites; Nitroglycerin; Papaverine; Perfusion; Phentolamine; Placenta; Pregnancy; Sodium; Sympatholytics; Tartrates; Tolazoline | 1968 |
[Recent progress in the knowledge of arterial hypertension. VII. Acute effects of antihypertensive drugs on kidney function].
Topics: Acute Disease; Animals; Antihypertensive Agents; Dogs; Female; Hemodynamics; Hydralazine; Hypertension; Kidney; Kidney Function Tests; Mecamylamine; Methods; Nitrates; Sodium | 1967 |
Drugs and the heart. VI. Vasodilating drugs.
Topics: Cardiotonic Agents; Chronic Disease; Heart Failure; Hemodynamics; Humans; Hydralazine; Hypertension; Nitrates; Nitroprusside; Oxygen Consumption; Vasodilator Agents | 1980 |
[Alternatives to digitalis therapy?].
Topics: Albuterol; Captopril; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Teprotide | 1981 |
[Alternatives to digitalis therapy].
Topics: Aminopyridines; Amrinone; Captopril; Catecholamines; Diuretics; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
Vasodilators for chronic congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vasodilator Agents | 1984 |
Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
Topics: Cardiac Output; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Muscle, Smooth, Vascular; Myocardium; Nitrates; Nitroglycerin; Oxygen Consumption; Pulmonary Wedge Pressure; Vasodilation | 1984 |
Drugs can help oesophageal motility disorders.
Topics: Esophageal Achalasia; Esophageal Diseases; Humans; Hydralazine; Nifedipine; Nitrates | 1984 |
Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Long-Term Care; Male; Middle Aged; Nitrates; Vasodilator Agents | 1981 |
Preload and afterload without anguish: a simplified framework.
Topics: Cardiac Output; Coronary Circulation; Heart Failure; Heart Function Tests; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1982 |
A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines; Spironolactone; Time Factors | 1983 |
Hydralazine in chronic CHF.
Topics: Administration, Oral; Aortic Valve Insufficiency; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Hypertension; Mitral Valve Insufficiency; Myocardial Contraction; Nitrates; Prazosin; Stroke Volume; Vascular Resistance | 1981 |
The longer term efficacy of vasodilators in heart failure.
Topics: Arteries; Heart Failure; Humans; Hydralazine; Nitrates; Vasodilator Agents; Veins | 1982 |
New approaches to therapy of acute heart failure.
Topics: Antihypertensive Agents; Dobutamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oxygen Inhalation Therapy; Prazosin | 1980 |
Vasodilator therapy of chronic congestive heart failure.
Topics: Ambulatory Care; Chronic Disease; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines | 1980 |
L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arginine; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclic GMP; Endothelins; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydralazine; Hydrazines; Hypertension; In Vitro Techniques; Indomethacin; Male; Methacrylates; Natriuresis; Nitrates; Nitrites; Nitroprusside; Rats; Rats, Inbred Dahl; Renal Artery; Thromboxane A2; Vasoconstriction | 2001 |
Treatment of congestive heart failure.
Topics: Angioedema; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Nitrates; Vasodilator Agents | 2002 |
[HYPERTENSION AND ANTIHYPERTENSIVE AGENTS].
Topics: Antihypertensive Agents; Diuretics; Ganglionic Blockers; Hydralazine; Hypertension; Methyldopa; Nitrates; Parasympathomimetics; Rauwolfia; Sympatholytics; Veratrum; Veratrum Alkaloids | 1963 |
Reversal of heart failure remodeling: is it maintained?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiomyopathies; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Heart Ventricles; Humans; Hydralazine; Male; Middle Aged; Mitral Valve Insufficiency; Nitrates; Retrospective Studies; Severity of Illness Index; Stroke Volume; Survival Analysis; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2003 |
The expression of heme oxygenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Guanidines; Heme Oxygenase-1; Hydralazine; Hypertension; Male; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Protoporphyrins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2004 |
Report from the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md.
Topics: Antihypertensive Agents; Black People; Cardiovascular Agents; Drug Combinations; Drug Labeling; Epidemiologic Measurements; Heart Failure; Humans; Hydralazine; Hypertension; Nitrates; Pediatrics; Renal Agents; United States; United States Food and Drug Administration | 2005 |
Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiac Resynchronization Therapy; Defibrillators, Implantable; Heart Failure; Heart-Assist Devices; Humans; Hydralazine; Ivabradine; Mineralocorticoid Receptor Antagonists; Nitrates; Renin-Angiotensin System; Risk Factors; Survival Analysis; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Nitrate therapy for heart failure: benefits and strategies to overcome tolerance.
Topics: Drug Tolerance; Heart Failure; Humans; Hydralazine; Nitrates; Vasodilator Agents | 2013 |
INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Resynchronization Therapy; Defibrillators, Implantable; Disease Progression; Female; Heart Failure; Heart-Assist Devices; Hospitalization; Humans; Hydralazine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nitrates; Outpatients; Prognosis; Prospective Studies; Quality of Life; Registries; Risk Assessment; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Vasodilator Agents | 2016 |
Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction.
Topics: Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Middle Aged; Nitrates; Stroke Volume; Vasodilator Agents | 2019 |
Vericiguat, organic nitrates, and heart failure in African Americans.
Topics: Black or African American; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Hydralazine; Isosorbide Dinitrate; Nitrates; Pyrimidines; Stroke Volume | 2021 |
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Combinations; Female; Guideline Adherence; Heart Failure; Humans; Hydralazine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mortality; Nitrates; Practice Guidelines as Topic; Quality of Health Care; Stroke Volume; United States; United States Department of Veterans Affairs; Valsartan; Veterans | 2022 |
Inpatient Quality-of-Care Measures for Heart Failure: Treatment Gaps and Opportunities in the Contemporary Era.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Heart Failure; Humans; Hydralazine; Inpatients; Mineralocorticoid Receptor Antagonists; Neprilysin; Nitrates; Receptors, Angiotensin; Stroke Volume | 2022 |